Cargando…

肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系

BACKGROUND AND OBJECTIVE: There exsits intimate relationship between infection with chlamydia pneumoniae (Cpn) and lung cancer incidence. But few studies have been reported about radiation-induced pulmonary lesion in lung cancer patients infected with Cpn. The aim of this study is to explore the cor...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999776/
https://www.ncbi.nlm.nih.gov/pubmed/21342643
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.02.05
_version_ 1783331506832277504
collection PubMed
description BACKGROUND AND OBJECTIVE: There exsits intimate relationship between infection with chlamydia pneumoniae (Cpn) and lung cancer incidence. But few studies have been reported about radiation-induced pulmonary lesion in lung cancer patients infected with Cpn. The aim of this study is to explore the correlation between cytokines related to radiation-induced pulmonary lesion and Cpn IgG positive in lung cancer patients. METHODS: A total of 69 patients with lung cancer received chest radiotherapy. Blood samples were collected and frozen before radiotherapy (pre-RT), middle radiotherapy (mid-RT) and after radiotherapy (post-RT). Cpn IgG and levels of IL-1β, SP-A, TGF-β, and TNF-α were measured by enzymelinked immunosorbent assay (ELISA). RESULTS: In the total of 69 patients, 21 patients were Cpn IgG positive, 48 patients negative. The positive rate was 30.43%. In mid-RT concentration of IL-1β in Cpn IgG positive and negative group were (35.82±10.09) ng/L and (30.01±6.46) ng/L, with statistically significant difference (P < 0.05). Pre-RT and post-RT concentrations of IL-1β in Cpn IgG positive and negative group had no statistically significant difference. Mid-RT concentrations of SP-A in Cpn IgG positive group and negative group were (641.78±106.81) ng/L and (100.86±61.4) ng/L respectively, with statistically significant difference (P < 0.05). Post-RT concentration of SP-A in Cpn IgG positive and negative group were (657.47±115.19) ng/L and (93.23±47.15) ng/L respectively, with statistically significant difference (P < 0.05). Concentrations of TNF-α in Cpn IgG positive and negative group had no statistically significant difference. Concentrations of TGF-β in Cpn IgG positive group were (710.67±358.16) pg/mL in pre-RT, (1, 002.06±542.16) pg/mL in mid-RT, (2, 125.16±1, 522.29) pg/mL in post-RT; those in negative group were (867.77±412.48) pg/mL, (914.05±425.70) pg/mL, (1, 073.36±896.01) pg/mL. Concentration of TGF-β in post-RT between Cpn IgG positive and negative group had statistically significant difference (P < 0.05). CONCLUSION: Cpn IgG positive in lung cancer patients influenced levels of IL-1β, SP-A, TGF-β during chest radiotherapy. This might aggravate radiation-induced pulmonary lesion.
format Online
Article
Text
id pubmed-5999776
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59997762018-07-06 肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: There exsits intimate relationship between infection with chlamydia pneumoniae (Cpn) and lung cancer incidence. But few studies have been reported about radiation-induced pulmonary lesion in lung cancer patients infected with Cpn. The aim of this study is to explore the correlation between cytokines related to radiation-induced pulmonary lesion and Cpn IgG positive in lung cancer patients. METHODS: A total of 69 patients with lung cancer received chest radiotherapy. Blood samples were collected and frozen before radiotherapy (pre-RT), middle radiotherapy (mid-RT) and after radiotherapy (post-RT). Cpn IgG and levels of IL-1β, SP-A, TGF-β, and TNF-α were measured by enzymelinked immunosorbent assay (ELISA). RESULTS: In the total of 69 patients, 21 patients were Cpn IgG positive, 48 patients negative. The positive rate was 30.43%. In mid-RT concentration of IL-1β in Cpn IgG positive and negative group were (35.82±10.09) ng/L and (30.01±6.46) ng/L, with statistically significant difference (P < 0.05). Pre-RT and post-RT concentrations of IL-1β in Cpn IgG positive and negative group had no statistically significant difference. Mid-RT concentrations of SP-A in Cpn IgG positive group and negative group were (641.78±106.81) ng/L and (100.86±61.4) ng/L respectively, with statistically significant difference (P < 0.05). Post-RT concentration of SP-A in Cpn IgG positive and negative group were (657.47±115.19) ng/L and (93.23±47.15) ng/L respectively, with statistically significant difference (P < 0.05). Concentrations of TNF-α in Cpn IgG positive and negative group had no statistically significant difference. Concentrations of TGF-β in Cpn IgG positive group were (710.67±358.16) pg/mL in pre-RT, (1, 002.06±542.16) pg/mL in mid-RT, (2, 125.16±1, 522.29) pg/mL in post-RT; those in negative group were (867.77±412.48) pg/mL, (914.05±425.70) pg/mL, (1, 073.36±896.01) pg/mL. Concentration of TGF-β in post-RT between Cpn IgG positive and negative group had statistically significant difference (P < 0.05). CONCLUSION: Cpn IgG positive in lung cancer patients influenced levels of IL-1β, SP-A, TGF-β during chest radiotherapy. This might aggravate radiation-induced pulmonary lesion. 中国肺癌杂志编辑部 2011-02-20 /pmc/articles/PMC5999776/ /pubmed/21342643 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.02.05 Text en 版权所有©《中国肺癌杂志》编辑部2011 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系
title 肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系
title_full 肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系
title_fullStr 肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系
title_full_unstemmed 肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系
title_short 肺癌患者肺炎衣原体IgG阳性与放射性肺损伤相关细胞因子的关系
title_sort 肺癌患者肺炎衣原体igg阳性与放射性肺损伤相关细胞因子的关系
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999776/
https://www.ncbi.nlm.nih.gov/pubmed/21342643
http://dx.doi.org/10.3779/j.issn.1009-3419.2011.02.05
work_keys_str_mv AT fèiáihuànzhěfèiyányīyuántǐiggyángxìngyǔfàngshèxìngfèisǔnshāngxiāngguānxìbāoyīnzideguānxì
AT fèiáihuànzhěfèiyányīyuántǐiggyángxìngyǔfàngshèxìngfèisǔnshāngxiāngguānxìbāoyīnzideguānxì
AT fèiáihuànzhěfèiyányīyuántǐiggyángxìngyǔfàngshèxìngfèisǔnshāngxiāngguānxìbāoyīnzideguānxì
AT fèiáihuànzhěfèiyányīyuántǐiggyángxìngyǔfàngshèxìngfèisǔnshāngxiāngguānxìbāoyīnzideguānxì